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Background: Asthma constitutes one of the most common chronic diseases in childhood, yet little is known 
about the factors that determine the outcome in childhood asthma. The purpose of this study was to describe 
various factors of potential importance for the outcome in children with intrinsic and extrinsic asthma. 
Methods: Of 85 consecutive children, 5-15 years of age with asthma, 70 (82%) participated in a lo-yr 
follow-up examination. At the time of referral, all children underwent certain tests for asthma (case history, 
total IgE, skin prick tests, radioallergosorbent (RAST) tests and specific bronchial provocations). On the basis 
of these tests, 24 children had intrinsic asthma and 46 children had extrinsic asthma. 
Results: At the follow-up examination, 60 of the 70 adults (86%, 20 with intrinsic asthma) had current 
symptoms; 54 of the 60 (900/,; 18 with intrinsic asthma) were receiving maintenance therapy. Both FEV, 
%predicted and FEVJFVC increased significantly (from 73% f 19% to 92% f 17% and from 75% f 13% to 
80% f 12% respectively) from childhood to early adulthood (P<O.OOOl and P<O.OOl, respectively); a 
matching amelioration of symptoms was observed (P<O.OOOl). Adults with current symptoms had a 
significantly lower FEV, %predicted at the time of follow-up (90% & 2% vs. 100% * 4%, PcO.02) but not in 
childhood (73% f 20% vs. 71% f loo/) than adults who had ceased wheezing. 
Conclusions: In children with intrinsic asthma, the outcome seems to be predicted by a combination of the 
initial frequency of symptoms (P=O.O4), initial FEV, (P=O.O02), active smoking (P=O.OOl) and age at onset 
of respiratory symptoms (P=O.OOl), whereas the initial FEV, (P<O.OOl) seems to be a strong predictor for the 
outcome in children with extrinsic asthma. These findings suggest that the pathogenic mechanisms underlying 
intrinsic and extrinsic asthma in children may differ. 
Introduction 
Bronchial asthma constitutes one of the most 
common chronic diseases in childhood (l), yet our 
knowledge of the long-term prognosis in children 
with asthma remains inadequate (2), especially con- 
cerning possible differences in the prognosis for chil- 
dren with extrinsic and intrinsic asthma. Recent work 
has shown that the prognosis with regard to decline 
in lung function is worse for adults with intrinsic 
asthma than for adults with extrinsic asthma (3). 
Furthermore, the prognosis for adults with intrinsic 
and extrinsic asthma was found to be influenced by 
different factors to some extent, which may suggest 
that the pathogenetic mechanisms behind intrinsic 
and extrinsic asthma may differ at least in adults. 
Whether this also applies for children with extrinsic 
and intrinsic asthma is at present unknown, but 
knowledge about these aspects may prove important 
not only for understanding the condition but also 
for counselling parents and patients concerning 
treatment and prognosis. 
A group of consecutive children, 5-l 5 years of age, 
was examined after an interval of approximately 
10 yr in order to investigate which factors are 
important for the outcome in childhood intrinsic and 
extrinsic asthma. This study determines the relation 
between FEV, at follow-up and sex, age, smoking 
habit, frequency of symptoms, age at debut and 
pulmonary function at the time of enrolment. 
Materials and Methods 
PATIENTS 
Received 25 April 1994 and accepted in revised form 20 March 1995. Between 1978-1980, 85 children born between 
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Hospital in Copenhagen. At the time of referral, all 
patients fulfilled the following criteria for asthma: 
(a) recurrent episodes of wheezing of more than 1-yr 
duration, (b) a paraclinical diagnosis of reversible 
obstructive pulmonary disease (4,5), and (c) absence 
of other known causes of obstructive pulmonary 
disease (6). 
The patients were divided into two groups: those 
with intrinsic asthma and those with extrinsic 
asthma. Patients with intrinsic asthma fulfilled the 
following criteria: (a) normal levels of serum IgE and 
(b) no evidence of extrinsic asthma from history, 
results of skin tests, radioallergosorbent (RAST) tests 
and, when doubtful, specific bronchial provocation 
tests (6). The remaining patients were defined as 
having extrinsic asthma. 
In 1990, the 85 patients were invited by letter to 
have a follow-up examination, of whom 70 were 
examined. Informed consent was obtained from all 
participating subjects, and the study was approved by 
the local Ethics committee. 
At both examinations, the patients were graded 
according to the frequency of episodes of wheezing 
within the last 12 months. We defined six grades. 
Grade 0 comprised subjects who had had no 
episodes of wheezing. 
Grade I comprised patients who had had five or 
less episodes of wheezing. 
Grade 2 comprised patients with a history of, on 
average, one episode of wheezing every month. 
Grade 3 comprised patients with a history of 
frequent wheezing, i.e. approximately once a week. 
Grade 4 comprised patients who gave a history 
of wheezing on most days. 
Grade 5 comprised patients with a history of 
persistent wheezing (daily symptoms) and symptoms 
at night (once or more a week). 
Exclusion criteria: Three patients who, at the time 
of follow-up, had a diagnosis of Hodgkin’s disease, 
rheumatoid arthritis and mixed connective tissue, 
respectively, were excluded from the study because 
of pulmonary involvement, radiation therapy and/or 
treatment with methotrexate, azathioprin and/or 
bleomycin. 
The subjects were asked to abstain from smoking 
for at least 2 h before the examination. They were 
asked not to take theophylline or an anti-histamine 
for at least 24 h, astemizole for 6 weeks, or an oral 
&agonist for 18 h, and not to use an inhaled 
bronchodilator for 6 h before the tests, (long- 
acting inhaled &agonists were not available in 
Denmark at the time of this study). They continued 
with any inhaled or oral corticosteroids they were 
using. 
METHODS 
History 
When the patients were first referred (1978-1980) 
data were obtained (primarily by two persons) con- 
cerning respiratory symptoms (debut, frequency and 
type), disposition to atopic diseases, and previous 
and actual treatment. 
At the examination in 1990, all patients were 
interviewed by one person about respiratory symp- 
toms (episodes of dyspnoea and wheezing, cough, 
phlegm production, and frequency of symptoms), 
number of emergency room visits and hospital 
admissions caused by asthma within the last 5 yr and 
use of anti-asthma medication (drugs and daily 
doses). Furthermore, all subjects reported whether 
they were current smokers, ex-smokers or life-long 
non-smokers, and for the first two categories, they 
reported the duration of smoking. Current and 
ex-smokers reported their daily tobacco consump- 
tion, and an estimate of their lifetime tobacco 
exposure was calculated as pack years [current 
tobacco consumption (g day - ‘) x duration of 
smoking (yr)/20]. 
Tests for extrinsic asthma 
Skin tests were performed by conventional prick 
tests using a panel of 84 allergens (spring-, summer- 
and autumn-pollen, animal hair and dander, house 
dust allergen and mite, moulds and food) (7) (ALK, 
Copenhagen). The skin prick test was performed with 
standard dilutions of allergens in 50% glycerol, using 
histamine HCl 1 mg ml ~ i in glycerol and glycerol as 
positive and negative control, respectively (7). The 
reactions were read after 15-20 min; wheal area 
(WA) was compared with the histamine wheal (HA) 
and classified as positive if WA > HA (7). 
Tests for allergen-specific IgE (Al-RAST) were 
performed with the aluminium-radioallergosorbent 
test according to Weeke (8). A modification of the 
RAST was routinely used, according to which a 
mixture of four or five allergens, a so-called pool, was 
used instead of a single allergen. The following pools 
were used: Pollen (birch, timothy, mugwort and 
oxeye daisy), moulds (Alernaria iridis, Aspergillus 
fumigatus, Cladosporium herbarum and Mucor 
racemosus), animals (horse, dog, cat, cow and guinea 
pig), food (cow’s milk, beef, chicken, pork, hen’s egg, 
rye flour, barley and soya bean) and other (house 
dust, Dermatophagoides farinea, D. pteronyssinus and 
duck feathers) (ALK, Copenhagen) (7). When the 
reaction to a pool was 10 sorbent units (SU) or 
above, the same serum was subjected to RAST 
with each separate allergen within the pool. The test 
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was classified as positive if the reaction was 
>20 su (7). 
The total serum IgE levels were determined by 
paper radioimmunosorbent test (PRIST, Pharmacia, 
Sweden) (ALK, Copenhagen). The upper normal 
limits for total serum IgE were defined according to 
Backer et al. (9) and Dirksen (7). 
The presence or absence of IgE-mediated allergy 
was re-evaluated at the follow-up examination by use 
of skin prick tests with 10 common allergens [birch, 
grass, mugwort, horse, dog, cat, house dust mites (D. 
farinae and D. pteronyssinus) and moulds (A. iridis 
and C. herbarum)] (ALK, Copenhagen) and measure- 
ments of total serum IgE (PRIST, Pharmacia, S), 
whereas RASTs were not performed. The results 
were evaluated as at the first examination. 
Pulmonary function tests (PFT) 
In 1978-1980, forced expiratory volume in 1 s 
(FEV,), forced vital capacity (FVC) and peak expi- 
ratory flow (PEF) were measured using an electronic 
spirometer (Spirotron, Drager). The highest of three 
acceptable post-bronchodilator measurements of 
FEV,, FVC and PEF obtained (for the youngest 
children within the first year after referral) were used 
in the analyses. 
In 1990, FEV,, FVC and PEF were measured with 
a pneumotachometer (Jaeger, Germany) and elec- 
tronically integrated to volume (FEV, and FVC), 
taking proper calibration into account; the highest of 
three acceptable readings was recorded. Further- 
more, the helium dilution technique was used for 
measuring total lung capacity (TLC) and residual 
volume (RV); haemoglobin-corrected diffusion 
capacity [TLCO, total diffusion capacity for carbon 
monoxide; KCO, diffusion capacity per 1 alveolar 
volume (T,COI V,)] was measured by single-breath 
carbon monoxide dilution (10). When the FEV,, 
after the bronchial challenge test with histamine, had 
returned to at least 95% of the baseline value (after at 
least 45 min) (1 l), the patients were tested for re- 
versibility. The FEV,, FVC and PEF were measured 
15 min after inhalation of 1 ml (5 mg ml - ‘) salbuta- 
mol delivered from a nebulizer (system 22, Spiro 
Pharma, Copenhagen). Reversibility in FEV, was 
calculated as (FEV, after-FEV, before)/FEV, before 
(5). Furthermore, subjects measured their PEF twice 
daily for 2 weeks (best of three measurements). 
Diurnal variability in PEF was defined, according to 
Clark and Hetzel (12,13) as (highest-lowest measure- 
ment during the observation period)/mean of all 
measurements. 
Data on pulmonary function are expressed as 
absolute values and as a percentage of predicted 
values (%predicted), using prediction equations 
based on age, sex and height (14,15). Unless stated 
otherwise, values obtained after administration of 
bronchodilator are used in the analyses. 
Bronchial challenge test 
The test was carried out by the method described 
by Cockcroft et al. (16). Aerosols of the test solution 
were generated by a Wright nebulizer (Aerosol 
Products, London) operated to give an output of 
0.14 ml min ~ I. Each aerosol was inhaled through 
the mouth by tidal breathing for 2 min. The first 
aerosol was saline (0.9%), and it was followed at 
4-min intervals by two-fold increasing concentrations 
of histamine (0.075 to 16.0 mg ml - ‘). The response 
was measured by the FEV, 1 min after each inhala- 
tion. Determination of nebulizer output by weight 
indicated that the histamine inhalation schedule 
corresponded to the following doses of histamine 
(nebulizer output) in ,uM: 0, 0.11, 0.23, 0.46, 0.98, 
1.83, 3.65, 7.30, 12.17 and 24.34. The same nebulizer 
was used throughout the study, and the output was 
tested regularly. The test was terminated when a 20% 
or more decline in FEV, from the post-saline value 
occurred, or at the end of the dose schedule if such a 
decline did not occur. 
For all subjects having at least a 20% decline in 
FEV,, the concentration of histamine causing a 20% 
fall in FEV, (PC,,) was calculated by linear interp- 
olation from the individual log dose-response curve 
as follows (17): 
PC,,= 
anti-log [logC, +(logC, - log C,)(20 - RJR 2 - R,)] 
where: C, = second last concentration of histamine 
(~20% FEV, fall) 
C, = last concentration of histamine (>20% 
FEV, fall) 
R, =% fall FEV, after C, 
R,=% fall FEV, after C, 
Histamine responsiveness was also analysed with 
use of an estimate of the overall slope of the dose- 
response relationship as described by O’Connor (18). 
The dose-response slope was calculated as the decline 
in FEV, from the post-saline value (expressed as a 
percentage of the post-saline value) after the final 
dose divided by the dose of histamine administered 
(18). 
Statistical methods 
Data were analysed with use of the statistical pack- 
age program Minitab (Minitab Inc., Birmingham). 
The continuous variables are presented as arithmetic 
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Table 1 General characteristics [mean and (SD)] of the 70 patients who participated in both 
examinations 
Intrinsic asthma Extrinsic asthma 
Females Males Females Males 
Sex (no) 
Age in 1990 (years) 
(range) 
Height (cm) 
1978-1980 
1990 
Persistent asthmatics (1990) 
Asthma grade 
1978-1980 
1990 
Age at debut1 
Smoking CSIEWMS (no) 
lpack years] 
7 
21 ‘k.4) 21 (2.9) 21 2;-s) 21 2;.7) 
(15-25) (1625) (16-25) (15-25) 
1.34 (0.18) 1.32 (0.14) 1.43 (0.15) 1.40 (0.13) 
1.68 (0.04) 1.80 (0.07) 1.68 (0.07) 1.80 (0.06) 
94% 57% 82% 92% 
3.7 (0.9)* 3.9 (l.l)* 3.0 (1.1) 3.3 (1.2) 
2.6 (1.6)* 1.6 (2.1)* 2.4 (1.7) 2.5 (1.5) 
6.0 (2.6)? 4.7 (2.3) 3.8 (2.l)t 3.5 (2.1) 
5/l/l 1 2/o/5 6/O/16 5/l/18 
[1.5 (0.9)] [2,0 (3.5)] [1.2 (2.3)] [0.9 (2.0)] 
*P<O.Ol (1978-1980 vs. 1990); tB0.01 (females with intrinsic asthma vs. females with extrinsic 
asthma); fAge at onset of respiratory symptoms; CS, current smoker; EX, ex-smoker; 
NS, life-long-non-smoker. 
means f SD and as geometric means (19). Groups 
were compared using paired and unpaired t-tests, 
analysis of variance and chi-square test as 
appropriate. 
Factors of possible importance for the outcome of 
childhood asthma (defined as FEV, %predicted at 
follow-up) were entered into a multiple regression 
model and non-significant variables were deleted by 
backward elimination to determine those associated 
with FEV, %predicted at follow-up. The data were 
analysed with type of asthma as an independent 
variable in the regression model, and with interaction 
terms between type of asthma and other independent 
variables to test for differences in the influence of 
independent variables on patients with intrinsic and 
extrinsic asthma. A P value of less than 0.05 was 
considered significant. 
Results 
Of the 70 (85%) patients who participated in the 
follow-up examination, 24 patients had intrinsic 
asthma and 46 patients had extrinsic asthma; the 
general characteristics of the patients are outlined in 
Table 1 (one patient died prior to follow-up from 
causes unrelated to asthma). The data of patients 
originally enrolled in the study were subdivided into 
data of the 14 children not re-examined (excluding 
the child who died) and data of the 70 children who 
were re-examined as adults. Between the 14 and 70 
children, no significant differences were found in 
mean values for age, FEV, and age at the onset of 
respiratory symptoms. 
The mean interval between the two examinations 
was 10.7 years (range 10-12 years). The severity of 
asthma tended to decrease from childhood to early 
adulthood both in subjects with intrinsic and extrin- 
sic asthma, although the change reached statistical 
significance in subjects with intrinsic asthma only 
(Table 1). The mean FEV, %predicted increased 
significantly from childhood to the time of follow-up 
in both females (from 75 & 21% to 94 f 17%; 
P<O.OOOl) and males (from 71 & 15% to 89* 17%; 
P<O.OOOl) (Fig. 1). Divided according to sex and 
type of asthma, the increase in FEV, %predicted did 
not reach the level of significance for males with 
intrinsic asthma (P=O.12), probably due to the small 
number of subjects in this group (Table 2). A similar 
but less pronounced increase in the FEV,/FVC ratio 
1978-1980 1990 1978-1980 1990 
Fig. I FEV, %predicted in childhood (first examination in 
1978-1980) and in adulthood (follow-up examination in 
1990) in subjects with intrinsic (a) and extrinsic (b) asthma. 
0, females; 0, males. 
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Table 2 Comparison of pulmonary function [mean and (SD)] at first (1978-1980) and second 
(1990) examination in 70 subjects with asthma 
Intrinsic asthma Extrinsic asthma 
Females Males Females Males 
$ 100 
5 
E! 50 
Sex (no) 
FEV, 
1978-1980 (%predicted) 
1990 (%predicted) 
FEV, reversibility 
1990 (%) 
FEVJFVC 
1978-1980 (%) 
1990 (%) 
Diurnal variability in PEF 
1990 (%) 
TLC 
1990 (%predicted) 
RV 
1990 (% predicted) 
TLC0 
1990 (%predicted) 
KC0 
1990 (O/predicted) 
PC,,,<16mgmlli~ 
(1990) (no) 
Dose-response curve (1990)** 
17 7 
72.6 (24)$ 65.0 (15) 
91.3 (16)$ 79.4 (21) 
9.3 (7.9) 
73 (W§ 
83 (13)§ 
29.1 (14.0) 
97.9 (11) 
101.0 (23) 
95.4 (15) 
89.0 (13) 
14yi7) 
7.8 (7.5) 
74 (14) 
77 (14) 
28.4 (21,2) 
82.0 (ll)* 
87.5 (24) 
97.7 (17)* 
95.9 (7) 
21?40) 
22 
76.7 (18)$ 
96.7 (18)$ 
5.9 (8.3) 
79 (13)ll 
84 (8)ll 
26.7 (15.2) 
95.9 (15) 
90.3 (21) 
97.3 (18) 
93.7 (18) 
3lps) 
24 
72.0 (15)$ 
91.2 (16)$ 
6.2 (6.8) 
74 (10) 
76 (12) 
31.3 (19.9) 
95.5 (12)f 
98.5 (23) 
114.5 (15) 
97.0 (13) 
4*&) 
*P<O.O5; tP<0.02; $P<O.O05 (1978-1980 vs. 1990); §P<O.O2 (1978-1980 vs. 1990); iiP<O.O5 
(1978-1980 vs. 1990); v&,FEV, histamine; **decline in FEV, from the post-saline value (%) 
after the final dose divided by the dose of histamine administered. 
(a) 
I--+ 
I I 
1978-1980 1990 
$ 100 
6 
5 50 
(b) 
1978-1980 1990 
Fig. 2 FEV,IFVC ratio in childhood and in adulthood in 
subjects with intrinsic (a) and extrinsic (b) asthma, see also 
legend to Fig. 1. 0, females, 0, males. 
was observed, statistically significant in females only 
(BO.01) (Fig. 2). 
In 1990, the number of subjects with current 
symptoms, that is, within the preceding 12 months, 
was 60 subjects (86%), 20 of these had intrinsic 
asthma (Table 3). Young adults with current symp- 
toms had reduced FEV, %predicted in adulthood but 
not in childhood, compared to adults who had ceased 
wheezing (Fig. 3). All the subjects with current symp- 
toms used medication, 54 subjects (90%; 18 with 
intrinsic asthma) received daily therapy, including 
Table 3 Data [mean and (SD)] on subjects with former (i.e. 
no symptoms within the preceding 12 months) (n= 10) and 
current (n=60) asthma at the examination in 1990 
Former 
asthmatics 
Current 
asthmatics P value 
Sex (female/male) 
Age (1990) 
Height (1990) (cm) 
Age of debut 
FEV, %predicted 
1978-1980 
1990 
FVC %predicted 
1978-1980 
1990 
FEVJFVC (%) 
1978-1980 
1990 
FEV, rev.? (1990) % 
DR%istamine (1990) 
515 
20 (0.6) 
176 (2) 
4.5 (0.8) 
70.8 (lo)* 
100.2 (4)* 
75.1 (lo)* 
99.8 (4)* 
78 (8)* 
87 (2)* 
4.1 (0.8) 
0.7 (0.1) 
34126 
21 (0.4) 
173 (1) 
4.3 (0.3) 
73.3 (20) 
89.8 (2)*. 
80.8 (20)* 
98.8 (2) 
75 (13) 
79 (2) 
7.6 (1.1) 
9.2 (2.8) 
ns 
ns 
ns 
ns 
ns 
co.02 
ns 
ns 
co.01 
co.01 
co.02 
co.005 
*P<O.OOOl (1978-1980 vs. 1990); tFEV, % reversibility, 
[(FEV, after - FEV, before)lFEV, before]*lOO. ns, not 
significant, For other abbreviations, see legend to Table 2. 
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asthma or extrinsic asthma, or when the two groups 
of subjects were combined. 
1978-1980 1990 19’78-1980 1990 
Fig. 3 FEV, %predicted (a) and FEV,/FVC ratio (b) in 
childhood (first examination in 1978-1980) and in adult- 
hood (follow-up examination in 1990) in former (that is, no 
symptoms within the 12 months prior to the follow-up 
examination in 1990) and current asthmatics. 0, current 
asthmatics; 0, former asthmatics. 
Among the subjects with extrinsic asthma, an 
increase in the number of subjects with a positive skin 
reaction to birch and grass increased from childhood 
to early adulthood, whereas the number of positive 
reactions to horse (primarily among females) and cat 
decreased. All subjects with extrinsic asthma had at 
least one positive skin reaction at the follow-up 
examination. 
three subjects receiving oral corticosteroids. Six 
subjects (two with intrinsic asthma) used &agonists 
on demand; 30 of the 54 subjects (56%, 14 with 
intrinsic asthma) received daily treatment with two or 
more drugs. 
Multiple linear regression was used to determine 
factors important for FEV, %predicted at follow-up 
in patients with intrinsic and extrinsic asthma (Table 
4). In children with intrinsic asthma the initial 
frequency of symptoms (grade of asthma), active 
smoking (no. of pack years), FEV, %predicted in 
childhood and age at onset of respiratory symptoms 
were significantly related to the FEV, %predicted 
at follow-up, whereas the FEV, %predicted at 
follow-up in children with extrinsic asthma seems to 
be primarily predicted by the FEV, %predicted in 
childhood. Substituting FEV, %predicted with 
FEV,/FVC ratio as the outcome variable in the 
regression model did not change these findings. 
Discussion 
Table 4 Factors important for the outcome (FEV, %predicted) of childhood asthma [FEV, 
% predicted at follow-up = (k, x IA) + (k, x EA)+(k, x sex x IA)+(k, x sex x EA)+(k, x FEV, 
%predicted in childhood x IA)+(k, x FEV, %predicted in childhood x EA)+(k, x grade of 
asthma x IA)+(k, x grade of asthma x EA)+(k, x age at onset x IA)+(k,, x age at onset X 
EA)+(k,, x no. of pack years x IA)+(k,, x no. of pack years x EA)] 
‘Outgrowing’ asthma may be common in children 
with only mild or infrequent symptoms (2), although 
it has been shown by Martin et al. (20) that many 
subjects who had ceased wheezing still had increased 
bronchial responsiveness to inhaled histamine, 
suggesting that the disease might only be quiescent. 
In children with moderate to severe asthma, out- 
growing asthma appears to be the exception rather 
than the rule. The present study showed, in 
keeping with findings in other studies (20), that only 
10 (14%) of the subjects apparently outgrew their 
disease. Furthermore, five of these 10 subjects had 
paraclinical findings (i.e. FEV, GXO%predicted, 
FEViIFVC ~75% and/or PC,,FEV, histamine 
<Smgml-‘, data not shown) suggesting persistent 
abnormalities in the airways. It seems, therefore, that 
even a number of the adults who apparently are 
symptom-free may in fact have persistent air-how 
limitation. 
No relationship was found between the age of the 
children at inclusion and the FEV, %predicted in 
early adulthood in subjects with either intrinsic 
The FEV, %predicted values obtained increased 
significantly from childhood to the time of follow-up 
in both females and males, which is likely explained 
by a combination of the simultaneous decrease in 
Predictor 
Sex 
FEV, %predicted* 
Grade of asthma* 
Age of debut t (years) 
Smoking (pack years) 
Intrinsic asthma (n = 24) Extrinsic asthma (n=46) 
Coeff. (SD) P value Coeff. 6”) P value 
- 1.5 (5.8) 0.85 - 2.3 (5.1) 0.65 
0.50 (0.15) 0.002 0.40 (0.17) <O.OOl 
- 1.7 (2.5) 0.04 - 1.2 (2.3) 0.18 
4.8 (1.4) 0.001 0.7 (1.2) 0.57 
- 4.0 (1.2) 0.001 - o-7 (1 3) 0.59 
*At first examination (childhood); tAge at onset of respiratory symptoms; IA, Intrinsic asthma; 
EA. Extrinsic asthma. 
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the severity of asthma and improvements in the 
treatment, especially increasing use of inhaled corti- 
costeroids (4 patients vs. 22 patients, respectively, 
data not shown). Although in keeping with findings 
reported by Roorda et al. (21), the use of different 
sets of prediction equations, based upon other popu- 
lations than the one studied, or later maturation with 
respect to lung development among children with 
asthma in general, might partly account for the 
differences in the obtained values. 
Previous studies of the importance of the age at 
which asthma begins as a predictor of subsequent 
disease have produced conAicting results (22-25). 
This study showed that increasing age at the onset of 
respiratory symptoms leads to a more favourable 
outcome in children with intrinsic asthma, whereas 
no such relation was found in children with extrinsic 
asthma. Our findings lend weight to the growing 
recognition of the importance of IgE-mediated 
allergy in asthma; and, therefore, that the type of 
asthma (intrinsic vs. extrinsic) should probably be 
taken into account in future studies of the outcome of 
childhood asthma. 
The diagnosis of asthma in subjects aged 5-30 
years poses relatively few difficulties, but, as the 
aetiology and pathogenesis of intrinsic asthma (also 
referred to as non-IgE-mediated asthma) is largely 
unknown, the diagnosis is primarily based upon 
exclusion criteria, i.e. the absence of demonstrable 
allergy (6). In the present study, IgE-mediated allergy 
in the subjects with intrinsic asthma was excluded by 
means of history, measurements of total IgE, skin 
prick tests, RASTs and, if the results of these tests 
were not conclusive, specific bronchial provocations. 
Furthermore, the absence of IgE-mediated allergy 
was confirmed at the follow-up examination (data 
not shown), as all the subjects with intrinsic asthma 
had a negative skin prick test and a total IgE within 
the normal range (7,9).We are therefore confident 
that the diagnosis in these patients is indeed intrinsic 
asthma; and, furthermore, that the differences dem- 
onstrated between factors important for the outcome 
of childhood intrinsic and extrinsic asthma probably 
reflect true differences in the underlying pathogenetic 
mechanisms. 
The patients in this study were initially referred 
from all over Denmark to the National University 
Hospital in Copenhagen. Therefore, they might have 
had more severe asthma or might have been more 
difficult to treat than patients with asthma in the 
general population. This is supported by the high 
proportion of children with intrinsic asthma (26). At 
the time of follow-up, only one-third of the patients 
were attending a hospital and the others were attend- 
ing their general practitioner. Although the patients 
in the present study may not be representative of the 
asthmatic population at large, our findings provide 
information on the natural history of childhood 
asthma. 
Comparable to the findings in the present study, 
Roorda (27) and Kokkonen (28) have reported, from 
follow-up studies of samples of asthmatic children, a 
high prevalence of persistent respiratory symptoms 
among young adults (aged 20-25 years), suggesting 
that the majority of children with asthma of such a 
degree that they are referred to a specialist will 
continue to have symptoms in adulthood. Previous 
studies have found that the prognosis for children 
with asthma is less favourable in female patients than 
in male patients (2,25,29). Combined with the present 
findings, this could be due to differences in the 
natural history of intrinsic and extrinsic asthma, as 
intrinsic asthma, although much less common than 
extrinsic asthma, is far more prevalent in girls than 
in boys. 
Although the number of pack years was limited, 
the incidence of active smoking (29%) was disturb- 
ingly high. No effect of active smoking (no. of pack 
years) on outcome of pulmonary function at 
follow-up was observed among the extrinsic asth- 
matics, whereas active smoking predicted a lower 
FEV, %predicted in early adulthood in patients with 
intrinsic asthma. Whether this might reflect differ- 
ences in the pathogenetic mechanisms underlying 
intrinsic and extrinsic asthma or is simply a question 
of the amount of tobacco consumption (Table 1) is 
not clear. However, patients with asthma should be 
strongly encouraged not to smoke. 
It could be argued that the relatively wide age 
range of the children at the time of inclusion com- 
bined with the time span between the two examin- 
ations may have influenced the findings, thereby 
making the interpretation less straightforward. How- 
ever, including age at enrolment in the regression 
model did not reveal a significant relationship 
between age at inclusion and outcome. So, although 
the age from lo-20 years is a time period when the 
severity of asthma changes in many patients, the age 
range of the studied subjects does not appear to 
preclude drawing conclusions from the findings. 
Furthermore, the main purpose of this study was to 
investigate potential differences in factors affecting 
outcome in childhood intrinsic and extrinsic asthma, 
and the age range at inclusion did not differ between 
the two groups of patients. 
Treatment with inhaled and/or oral corticosteroids 
greatly influences the symptoms and signs of asthma. 
However, the present study used a symptom score 
554 C. S. Ulrik et al. 
based solely on the reported severity of symptoms, 11. Gerritsen J, Koeter GH, Akkerboom HJ, Knol K. 
instead of an overall severity score which also takes Recovery of FEV, after histamine challenge in 
use of anti-asthma medication into account. asthmatic children. Clin Allergy 1987; 17: 119-126. 
In conclusion, this study of the outcome of child- 
12. Hetzel MR, Clark TJH. Comparison of normal and 
hood asthma showed that although most of the 
asthmatic circadian rhythms in peak expiratory flow 
rate. Thorax 1980; 35: 732-738. 
subjects still had respiratory symptoms in early adult- 13. Clark TJH, Hetzel MR. Diurnal variation of asthma. 
Br J Dis Chest 1977 71: 87-92. hood, an improvement in -both pulmonary function 
and symptoms were noted. Furthermore, the out- 
come of childhood intrinsic asthma appears to be 
predicted not only by the initial FEV, but also by the 
initial frequency of symptoms, smoking habits and 
the age at which asthma begins, whereas the out- 
come in children with extrinsic asthma seems to be 
primarily predicted by the initial level of pulmonary 
function. 
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